Cognitive profiling in a cohort of Huntington’s disease (HD) patients
Objective: To define neuropsychological profile of HD patients adopting Parkinson’s disease Level II criteria for cognitive diagnosis[1]. Background: HD is a rare autosomal dominant genetic…Video-oculographic biomarkers for evaluating vertical ocular dysfunction in progressive supranuclear palsy
Objective: Objective: PSP patients typically show reduced amplitude and velocity of vertical saccades, but saccadic abnormalities have also been reported in PD. We investigated the…Case report: Parkinsonim with dyskinesia secondary to amyloid angiopathy
Objective: To report a case of parkinsonism secondary to amyloid angiopathy and discuss the pathophysiology and treatment of this entity. Background: Cerebral amyloid angiopathy is…Comparison of Voice, Speech, Swallowing and Drooling Problems in Parkinson’s Disease Patients with Healthy Individuals
Objective: To compare voice, speech, swallowing and drooling problems in Parkinson's disease (PD) patients with healthy individuals (HI) by using objective and subjective methods and…Feasibility Of An Intensive Inpatient Parkinson’s Rehabilitation Program For Moderately Advanced Parkinson’s Disease
Objective: To determine the feasibility in the US of a multimodal intensive inpatient Parkinson’s Rehabilitation program for patients with moderately advanced Parkinson’s disease (PD) Background:…Effects of Virtual Reality Immersion Level on Exercise Intensity and Motivation for Persons with Parkinson Disease
Objective: The purpose of this study was to determine the effect of immersion level in virtual reality (VR) on exercise intensity and motivation for persons…Regular Exercise Regimen Associated with Reduced Prevalence of Depression in Parkinson’s Disease
Objective: To evaluate the association between exercise and depression in people with Parkinson’s disease (PD). Background: Depression and other neuropsychiatric disturbances are prevalent non-motor features…A Phase 2 Clinical Trial Evaluating the Efficacy, Safety, Tolerability, and Pharmacokinetics of PRAX-944 in Adults with Essential Tremor
Objective: We present preliminary findings from PRAX-944-221, a Phase 2a clinical trial evaluating efficacy, safety, tolerability, and pharmacokinetics of PRAX-944 in adults with essential tremor…At-home prolonged adaptive deep brain stimulation improves symptoms and reduces side effects in Parkinson’s disease
Objective: Objective: To assess the effect of at-home adaptive deep brain stimulation (aDBS) on symptoms and treatment-associated side-effects in one patient with Parkinson’s disease (PD),…Impact of SARS-CoV-2 vaccine in Parkinson’s disease
Objective: To evaluate the impact of SARS-CoV-2 vaccine on motor and non-motor symptoms in Mexican people with Parkinson's disease (PwP). Background: Nowadays, as a consequence…
- « Previous Page
- 1
- …
- 60
- 61
- 62
- 63
- 64
- …
- 153
- Next Page »